Purpose: The purpose of this study was to examine associations between the number and types of patients' chronic diseases and being up to date for breast, cervical, and colorectal cancer screening.
health disparities exist among different populations that require attention, such as rural residents. [11] [12] [13] [14] [15] [16] Distance from metropolitan areas, underserved race or ethnicity, and other socioeconomic factors all influence receipt of cancer screening. 8, 15, 17 Even when access is not a problem, lack of health maintenance visits and lack of physician recommendations are barriers to cancer screening tests. 18 The presence of one or more chronic diseases may make receipt of cancer screening even more complex. Some chronic illnesses, such as diabetes, serve as independent risk factors for certain cancers 19 -21 and may be associated with cancer mortality, 22 while also serving as barriers to receipt of screening. [23] [24] [25] Conversely, other studies found the presence of chronic diseases is associated with better cancer screening utilization. Patients with hypertension have been reported to have more breast exams, Papanicolaou tests, and fecal occult blood tests compared with those without it, and mammography, breast exams, and Papanicolaou tests have been found to be higher in women with Ն3 chronic conditions. 26 -29 How chronic diseases affect screening of breast, cervical, and colorectal cancers remains controversial. The conflicting findings reported in the literature cited above may be because of the different settings, time periods during which recommendations for cancer screening changed, and geographic locations time periods being studied. Managing chronic illnesses and providing cancer screening may compete for clinicians' limited time in busy primary care settings, 30, 31 whereas more frequent clinic visits for chronic conditions may present opportunities for cancer screening. Work is still needed to achieve the Healthy People 2020 goals of colorectal, breast, and cervical cancer screening rates of 70.5%, 81.1%, and 93%, respectively. 32 Our study focused on several tests for breast, cervical, and colorectal cancer screening within a single time period and geographic location-rural understudied primary care practices-and specifically examined the impact of 16 different chronic conditions on being up to date for cancer screening while adjusting for potential confounders. We specifically tested the hypothesis that there is an inverse relationship between the number of comorbid conditions that patients had and the likelihood that they would be up to date for any cancer screening tests.
Methods

Study Design, Setting, and Population
We performed a medical record review with the Oregon Rural Practice-based Research Network. Study design and data collection were detailed in a recent publication. 15 Briefly, data were collected from medical charts at 4 primary care clinics located in 2 rural Oregon communities. Eligibility criteria for patients included being at least 55 years old (to ensure they met screening criteria); having at least 1 clinic visit in the past 2 years; and having medical records extending up to 10 years before the date of the review. All study activities were approved by the institutional review board of Oregon Health & Science University and conducted under a Health Insurance Portability and Accountability Act waiver for collection of personal health information without consent.
Data Collection/Medical Record Review
Medical records were reviewed between October 2008 and August 2009. We collected dates when eligible patients received colorectal, breast, and cervical cancer screening for up to 10 years. Colorectal cancer screening tests included fecal occult blood tests, colonoscopy, flexible sigmoidoscopy, and double-contrast barium enema; breast cancer screening included mammography; and cervical cancer screening included the Papanicolaou test (Papanicolaou).
We collected patients' demographic information; health insurance status; personal and family history of cancers and type of cancer; prior abnormal screening test results for colorectal, breast, or cervical cancers; numbers and types of chronic conditions from problem lists or patient notes; years of care received by clinic; total number of clinic visits; and type of clinic visit (health maintenance vs acute care or chronic care). The 16 chronic conditions were collapsed into the following 10 categories for analysis: (1) arthritis/musculoskeletal disease/degenerative joint disease, (2) asthma/emphysema/ chronic obstructive pulmonary disease/chronic lung disease, (3) cardiovascular disease, (4) hypertension, (5) chronic digestive disease, (6) chronic pain, (7) low-back pain, (8) diabetes mellitus, (9) depression/anxiety, and (10) substance abuse. The grouping decisions were made with input from the physician investigators on our team (L.F., D.B., and J.H.) and reflected common management ap-proaches. We grouped these diseases into a discrete variable. Unlike the Charlson index, 33 our variable for number of chronic conditions is not an aggregated predictor of mortality risk from chronic conditions.
For up-to-date status of cancer screenings, we used the US Preventive Services Task Force guidelines 34 -36 in effect during the chart review period (2008/2009). Subjects were considered up to date if the most recent screening mammography, Papanicolaou, or colorectal cancer screening test was recorded to have been within the appropriate screening time interval for their risk status (eg, family history in a first-degree relative).
Data Exclusions and Statistical Analysis
The initial data abstraction included 3593 patients, of whom we excluded 160, for a total of 3433. We excluded patients whose age was missing (n ϭ 5) and those with any personal history of breast, cervical, ovarian, or colorectal cancer (n ϭ 155). In our analyses of breast cancer screening, we also excluded women with a recent history of an abnormal mammogram because we could not be certain whether a patient had returned for screening or diagnostic mammography. Similarly, for analyses of cervical cancer screening, we excluded women with recent abnormal Papanicolaou tests because the follow-up could include other Papanicolaou, invasive sampling, or human papillomavirus testing, and there is uncertainty of a diagnosis of cancer. We excluded patients with a history of abnormal colorectal screening examination because these circumstances could also indicate an impending cancer diagnosis, making these patients more similar to those we excluded because of a personal history of cancer. For colorectal cancer screening, we did not exclude those from whom a polyp had been removed because return for surveillance or screening is clearer than it is for mammography and the time interval for return is longer than it is for abnormal mammography and Papanicolaou tests.
We calculated coefficients for agreement between the 2 medical record reviewers for all abstracted variables. We excluded 2 chronic conditions with values 37, 38 
Results
Study Population
We identified 503 patients (15%) who had no chronic illness, 646 (19%) with 1, 786 (23%) with 2, and 1498 (44%) with Ն3 conditions (Table 1) . The mean and median numbers of chronic conditions were 2.44 and 2, respectively (range, 0 -10) (data not shown). Of patients 49% were up to date for breast cancer screening, 52% for cervical cancer screening, and 37% for colorectal cancer screening (using any screening test). The number of chronic disease conditions was significantly different for many patient characteristics, including community of residence, patient age, race and ethnicity, marital status, occupation, insurance coverage, BMI, other health habits such as smoking history and alcohol use, and types of chronic illnesses ( Table 1 ). The mean length of contact with a clinic and the mean number of clinic visits both increased with increasing number of conditions. The most common chronic disease was hypertension, which was present in 48% of all patients and 27% of patients with only one chronic disease (Table 1) . Of those patients with 2 conditions, many had arthritis or other joint diseases (26%) and hypertension (53%). Of those patients with Ն3 conditions, most had hypertension (71%) or arthritis/joint diseases (59%), and many had cardiovascular disease (40%), chronic digestive disorders (40%), depression (45%), and/or low-back pain (42%).
Breast Cancer Screening
Of the 1870 women identified for the study, 1859 were included in the analysis of breast cancer screening status. Six women were excluded because they had an abnormal mammogram within 2 years of the chart review, 4 women had bilateral mastectomies, and 1 woman was transgender. The unadjusted odds of being up to date for mammography increased with one or more chronic diseases ( Table  2 ). Analyses that adjusted only for the total number of visits indicated that women with Ն3 chronic conditions were less likely to be up to date compared with those with no chronic conditions (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.45-0.87) ( Table 2 ). In the fully adjusted model, the negative association of Ն3 chronic conditions with mammography decreased in magnitude and was not statistically significant. Because having a digestive disorder was consistently associated with being up to date for mammography screening (Table 3) , we also tested the association in women without chronic digestive disorders. Excluding patients with digestive disorders reduced the odds of being up to date for mammography for women with 2 chronic conditions and women with Ն3 conditions (Table 2) .
Logistic regression modeling found that asthma/ chronic obstructive pulmonary disease/chronic lung disease, cardiovascular disease, and chronic digestive disorder were all significantly associated breast cancer screening status (Table 3 ). In our final adjusted models, women with asthma/chronic lung disease (OR, 0.59; 95% CI, 0.43-0.80) and with cardiovascular disease (OR, 0.71; 95% CI, 0.54 -0.94) were less likely to be up to date for mammography screening, and those with chronic digestive disorders were more likely to be up to date (OR, 1.31; 95% CI, 1.03-1.66).
Cervical Cancer Screening
Of the 1870 women in the study, 1103 were younger than age 65. Of these women, 373 were excluded from the analysis because of a history of hysterectomy (n ϭ 350) or abnormal cervical cancer screenings within the past 2 years (n ϭ 23), leaving 740 women in the analysis. The unadjusted odds of being up to date for cervical cancer screening were not significantly different according to the number of chronic conditions (Table 4) . When adjusted for the number of clinic visits alone or for numerous patient characteristics, women with 2 chronic conditions (OR, 0.55; 95% CI, 0.31-0.95) or Ն3 chronic conditions (OR, 0.38; 95% CI, 0.21-0.68) were less likely to be up to date for cervical cancer screening than women with no chronic conditions. When the analysis was limited to women with no digestive disorders, the negative association of having 2 chronic conditions with cervical cancer screening status was not statistically significant.
In unadjusted models, hypertension was the only chronic disease significantly associated with cervical cancer screening status. Three chronic diseases-arthritis/degenerative joint disease, diabetes mellitus, and hypertension-were significantly associated with lower odds of being up to date for cervical cancer screening in analyses that adjusted for marital status, BMI, number of visits, and other chronic diseases (Table 5) .
Colorectal Cancer Screening
In unadjusted analyses, men and women with Ն3 chronic diseases were significantly more likely to be up to date for colorectal cancer screening than those with no chronic conditions (men: OR, 1.44; 95% CI, 1.03-2.02; women: OR, 1.37; 95% CI, 1.02-1.84) (Table 6 ). However, when adjusted for the number of visits in the past 5 years, these patients were significantly less likely to be up to date (men: OR, 0.61; 95% CI, 0.41-0.91; women: OR, 0.62; 95% CI, 0.44 -0.89). When fully adjusted for covariates, the negative association of colorectal screening with the number of chronic conditions lost statistical significance; however, when patients with chronic digestive disorders were excluded from the analysis, the negative association with Ն3 chronic conditions was statistically significant (Table 6 ).
Male patients with cardiovascular disease were significantly less likely to be up to date for colorectal cancer screening (adjusted OR, 0.59; 95% CI, 0.44 -0.80), whereas men with chronic digestive Table 7) . As with the male patients, an unadjusted analysis found that women with low back pain were more likely to be up to date; however, no association was observed in the adjusted analysis. 
Discussion
In general, we found that an increase in the number of chronic conditions was associated with decreased screening rates, which is what we hypothesized and has been reported elsewhere. 25, 39 The magnitude and statistical significance of this effect was most pronounced for cervical cancer screening, which surprised us; we hypothesized that all cancer screening tests would be affected similarly. In addition, we were surprised to find that certain chronic diseases have more of an effect on up-to-date screening status than others for different cancers. Of the 7 types of chronic disease associated with up-to-date status, all but one was associated with decreased odds of being up to date. One category of chronic disease, digestive disorders, was associated with increased odds of being up to date for breast cancer screening and for colorectal cancer screening. The specific reasons for these associations cannot be determined from this study, but a number of pos- sibilities can be considered. It may be that constipation, diarrhea, or other types of digestive disorders resulted in a referral for colonoscopy, resulting in these patients being more likely to be up to date for colorectal cancer screening. Perhaps this triggered an additional referral for mammography because women needed to go to the hospital for the one test and were subsequently more likely to get the other. For cervical cancer screening, we found arthritis/musculoskeletal disease/degenerative joint disease, diabetes mellitus, and hypertension each to be associated with lower likelihood of being up to date for Papanicolaou. This may be because Papanicolaou tests are in-office procedures, which would compete for time with other health priorities during a clinic visit. Also, women with arthritis might experience pain and movement difficulties for the Papanicolaou procedure, reducing the likelihood that they will be done. The lower ORs persisted after our adjustments for length of contact and number of clinic visits, which suggests that the type of health care visit (health maintenance visits) is more important than the number of health care visits.
The likelihood of being up to date for colorectal cancer screening was lower among men, but not among women, with cardiovascular disease. In women, we found diabetes and depression/anxiety to be associated with a lower likelihood of being up to date for colorectal cancer screening. For both men and women, having a chronic digestive disorder increased the likelihood of being up to date. Past studies showed that having heart disease is associated with lower rates of colorectal cancer screening. 31 Because men generally have higher rates of heart disease, we postulate that physicians spend more time counseling and managing heart disease among men than women. Fitting cancer screening, as opportunistic events, into brief health care visits may be more difficult when the visits are for conditions that require alterations in medication management, as occurs with cardiovascular disease, diabetes, and anxiety/depression. Also, colonoscopy, whether used as a primary screening tool or as a follow-up to an abnormal less-invasive test, is perceived to carry greater risk for those with certain chronic diseases. This could affect provider and patient willingness to screen these populations. On the other hand, our finding that patients with a digestive disorder are more likely to be up to date, especially with colonoscopy, may be because colonoscopy is used both as a screening test and a diagnostic test to rule out any potential areas of concern related to the large bowel. We found it interesting that women with depression were less likely to be up to date for colorectal cancer screening but not for breast or cervical cancer screenings. Counseling for depression in primary care can be time consuming and may be a higher and more urgent priority for patients than preventive care, which might have caused a delay in addressing cancer screening needs. Colorectal screening, which requires bowel preparation and occurs outside of the primary care clinic, tends to be perceived as a more unpleasant and time-consuming experience than breast or cervical cancer screening, involving extra barriers for patients to overcome. 8 These barriers may be particularly challenging for depressed patients.
In unadjusted analyses, low-back pain was significantly associated with being more likely to be up to date for colorectal cancer screening among both men and women. Low-back pain is a common diagnosis and often difficult to manage. Low-back pain is sometimes related to the presence of tumors, which might prompt conversations of colorectal cancer screening. Importantly, this finding did not persist after multivariable adjustments for patient and health care visit characteristics, suggesting that the finding is related to one or more of the covariates included in the analysis, such as patient age or BMI.
Physicians should consider the potential benefits of screening for these 3 cancers, as suggested by the US Preventive Services Task Force. [1] [2] [3] However, decisions about cancer screening should weigh the benefits and harms for individual patients, rather The strengths of our study include our focus on both individual and total number of chronic diseases. Past studies often used a combined comorbidity index, such as the Charlson index, 34 or focused on a specific disease, such as patients with diabetes or cardiovascular disease. [21] [22] [23] 29, 40 Our findings showed that individual chronic conditions have a varied impact on one's up-to-date status for cancer screening. Understanding why this occurs would facilitate more appropriate screenings and meeting the goals of Healthy People 2020.
Other strengths include our use of medical chart review rather than patient self-report, which suffers from social response bias and recall bias. 41 By recording actual completion of screening tests rather than physician recommendations, we could obtain more accurate, objective records of if and when screening tests were done. In addition, our study included screening for 3 relatively common cancers that all have specific screening recommendations for primary care clinicians. Last, we focused this study on rural underserved and understudied patients. Because prior studies showed that access to physicians plays a significant role in receiving appropriate cancer screening, we tried to eliminate this factor by abstracting charts at primary care clinics, where patients have an established relationship. 40 Potential limitations of our study included missing patient information, such as insurance and ethnicity; in addition, we did not collect information on specific patient and physician perspectives on the impact chronic diseases can have on cancer screening. The latter would further elucidate potential barriers to screening. Missing information regarding patient characteristics and demographics could lead to information bias; however, we included in our analysis a category of "not noted" to account for any impact this category may have on screening status. We used patients with "no disease" as our referent group, which might have resulted in lower ORs than what might be found in those who are sick. However, the screening rates for those with "no disease" under the categories that we examined were low (Ͻ50%), despite the opportunity for more preventive visits for those patients. For our cervical cancer screening analysis, we only included women between 55 to 65 years old, which precluded understanding cervical cancer screening among patients younger than age 55. We were not able to collect information regarding patients' functional status and quality of life, which would help us further assess relationships between chronic disease and cancer screening. Another limitation is the possible lack of representativeness due to patients being from 4 rural clinics in a single state. In addition, we do not how the numbers of comorbid chronic conditions and the prevalence of chronic diseases compare with other study samples, which may indicate our level of representativeness.
In the future, it will be useful to gather information on patients' and physicians' perspectives on cancer screenings and determine how best to fit cancer screening into opportunistic visits for those with multiple chronic conditions. Real-time observations might capture discussions about the risks, benefits, and overall value of screening in patients whose life expectancy might be uncertain. Interventional studies could also be done to evaluate how best to improve screening among those patients with conditions that bear less risk of mortality, such as depression and low-back pain, as well as for those patients with multiple high-risk diseases in the context of their other health priorities.
Conclusion
We found that specific types of chronic conditions have a larger effect on being up to date for cancer screening than the total number of conditions. When the number of conditions reached 3 or more, however, they also had an impact on screening status, especially for cervical cancer screening.
